Miglustat

CHEMBL1029 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

219.3 g/mol

LogP

-0.6

Phase

4

This oral medication reduces the production of certain fatty substances that accumulate harmfully in cells in people with specific inherited enzyme deficiency disorders. It is used to treat Gaucher disease and Niemann-Pick type C disease.

分子量

219.2800 g/mol

LogP

-0.60

TPSA

84.20 Å²

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO

InChI

InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1

Molecular Formula

C10H21NO4

HBD / HBA

4 / 5

回転可能結合数

4

重原子数

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This oral medication reduces the production of certain fatty substances that accumulate harmfully in cells in people with specific inherited enzyme deficiency disorders. It is used to treat Gaucher disease and Niemann-Pick type C disease.

Yes, Miglustat is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1029. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 51634. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Miglustat PillFYIで

構造

クイックデータ

分子式: C10H21NO4
同義語: 3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.